Literature DB >> 33466285

Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models.

Clara Depommier1, Nicolas Flamand2, Rudy Pelicaen1, Dominique Maiter3,4, Jean-Paul Thissen3,4, Audrey Loumaye3,4, Michel P Hermans3,4, Amandine Everard1, Nathalie M Delzenne1, Vincenzo Di Marzo2,5,6, Patrice D Cani1.   

Abstract

The global obesity epidemic continues to rise worldwide. In this context, unraveling new interconnections between biological systems involved in obesity etiology is highly relevant. Dysregulation of the endocannabinoidome (eCBome) is associated with metabolic complications in obesity. This study aims at deciphering new associations between circulating endogenous bioactive lipids belonging to the eCBome and metabolic parameters in a population of overweight or obese individuals with metabolic syndrome. To this aim, we combined different multivariate exploratory analysis methods: canonical correlation analysis and principal component analysis, revealed associations between eCBome subsets, and metabolic parameters such as leptin, lipopolysaccharide-binding protein, and non-esterified fatty acids (NEFA). Subsequent construction of predictive regression models according to the linear combination of selected endocannabinoids demonstrates good prediction performance for NEFA. Descriptive approaches reveal the importance of specific circulating endocannabinoids and key related congeners to explain variance in the metabolic parameters in our cohort. Analysis of quartiles confirmed that these bioactive lipids were significantly higher in individuals characterized by important levels for aforementioned metabolic variables. In conclusion, by proposing a methodology for the exploration of large-scale data, our study offers additional evidence of the existence of an interplay between eCBome related-entities and metabolic parameters known to be altered in obesity.

Entities:  

Keywords:  LBP; NEFA; endocannabinoidome; endocannabinoids; human; leptin; metabolic syndrome; multivariate analysis; obesity

Year:  2021        PMID: 33466285      PMCID: PMC7824762          DOI: 10.3390/cells10010071

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  59 in total

Review 1.  Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.

Authors:  Caroline Turcotte; François Chouinard; Julie S Lefebvre; Nicolas Flamand
Journal:  J Leukoc Biol       Date:  2015-04-15       Impact factor: 4.962

2.  Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

Authors:  M Côté; I Matias; I Lemieux; S Petrosino; N Alméras; J-P Després; V Di Marzo
Journal:  Int J Obes (Lond)       Date:  2007-01-16       Impact factor: 5.095

3.  Docosahexaenoic acid attenuates in endocannabinoid synthesis in RAW 264.7 macrophages activated with benzo(a)pyrene and lipopolysaccharide.

Authors:  Joanna Gdula-Argasińska; Beata Bystrowska
Journal:  Toxicol Lett       Date:  2016-06-18       Impact factor: 4.372

4.  Leptin-regulated endocannabinoids are involved in maintaining food intake.

Authors:  V Di Marzo; S K Goparaju; L Wang; J Liu; S Bátkai; Z Járai; F Fezza; G I Miura; R D Palmiter; T Sugiura; G Kunos
Journal:  Nature       Date:  2001-04-12       Impact factor: 49.962

Review 5.  Role of the endocannabinoid system in diabetes and diabetic complications.

Authors:  G Gruden; F Barutta; G Kunos; P Pacher
Journal:  Br J Pharmacol       Date:  2015-08-20       Impact factor: 8.739

6.  Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes.

Authors:  Laurent Genser; Doriane Aguanno; Hédi A Soula; Liping Dong; Laurence Trystram; Karen Assmann; Joe-Elie Salem; Jean-Christophe Vaillant; Jean-Michel Oppert; Fabienne Laugerette; Marie-Caroline Michalski; Philippe Wind; Monique Rousset; Edith Brot-Laroche; Armelle Leturque; Karine Clément; Sophie Thenet; Christine Poitou
Journal:  J Pathol       Date:  2018-08-28       Impact factor: 7.996

Review 7.  Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.

Authors:  Fabio Arturo Iannotti; Vincenzo Di Marzo; Stefania Petrosino
Journal:  Prog Lipid Res       Date:  2016-03-07       Impact factor: 16.195

8.  Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties.

Authors:  Michiel G J Balvers; Kitty C M Verhoeckx; Pierluigi Plastina; Heleen M Wortelboer; Jocelijn Meijerink; Renger F Witkamp
Journal:  Biochim Biophys Acta       Date:  2010-06-27

9.  Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.

Authors:  Francesca Borrelli; Barbara Romano; Stefania Petrosino; Ester Pagano; Raffaele Capasso; Diana Coppola; Giovanni Battista; Pierangelo Orlando; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

Review 10.  Cannabinoids and the expanded endocannabinoid system in neurological disorders.

Authors:  Luigia Cristino; Tiziana Bisogno; Vincenzo Di Marzo
Journal:  Nat Rev Neurol       Date:  2019-12-12       Impact factor: 42.937

View more
  4 in total

1.  Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists.

Authors:  Clara Depommier; Rosa Maria Vitale; Fabio Arturo Iannotti; Cristoforo Silvestri; Nicolas Flamand; Céline Druart; Amandine Everard; Rudy Pelicaen; Dominique Maiter; Jean-Paul Thissen; Audrey Loumaye; Michel P Hermans; Nathalie M Delzenne; Willem M de Vos; Vincenzo Di Marzo; Patrice D Cani
Journal:  Cells       Date:  2021-01-19       Impact factor: 6.600

Review 2.  Endocannabinoids and the Gut-Brain Control of Food Intake and Obesity.

Authors:  Nicholas V DiPatrizio
Journal:  Nutrients       Date:  2021-04-07       Impact factor: 5.717

Review 3.  (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders.

Authors:  Jyoti Sihag; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2022-01-14       Impact factor: 3.876

4.  Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome.

Authors:  Clara Depommier; Amandine Everard; Céline Druart; Dominique Maiter; Jean-Paul Thissen; Audrey Loumaye; Michel P Hermans; Nathalie M Delzenne; Willem M de Vos; Patrice D Cani
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.